-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Checkpoint Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q2 2024.
- Checkpoint Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.18 USD/shares, a 82.9% increase year-over-year.
- Checkpoint Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.74 USD/shares, a 68% increase year-over-year.
- Checkpoint Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.17 USD/shares, a 55.3% increase from 2022.
- Checkpoint Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -7.09 USD/shares, a 4.83% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)